243 related articles for article (PubMed ID: 10873965)
1. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions.
Vos K; Steenbakkers P; Miltenburg AM; Bos E; van Den Heuvel MW; van Hogezand RA; de Vries RR; Breedveld FC; Boots AM
Ann Rheum Dis; 2000 Jul; 59(7):544-8. PubMed ID: 10873965
[TBL] [Abstract][Full Text] [Related]
2. Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions.
Vos K; Miltenburg AM; van Meijgaarden KE; van den Heuvel M; Elferink DG; van Galen PJ; van Hogezand RA; van Vliet-Daskalopoulou E; Ottenhoff TH; Breedveld FC; Boots AM; de Vries RR
Rheumatology (Oxford); 2000 Dec; 39(12):1326-31. PubMed ID: 11136874
[TBL] [Abstract][Full Text] [Related]
3. [Human cartilage glycoprotein 39 mRNA expression in peripheral blood and synovium mononuclear cells in rheumatoid arthritis].
Shen M; Zeng XJ; Tang FL
Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):928-31. PubMed ID: 15730740
[TBL] [Abstract][Full Text] [Related]
4. Serum human cartilage glycoprotein-39 levels in patients with systemic lupus erythematosus.
Wcisło-Dziadecka D; Kotulska A; Brzezińska-Wcisło L; Kucharz EJ; Lis-Swiety A; Kamińska-Wiciorek G
Pol Arch Med Wewn; 2009 Dec; 119(12):777-84. PubMed ID: 20010462
[TBL] [Abstract][Full Text] [Related]
5. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis.
Baeten D; Boots AM; Steenbakkers PG; Elewaut D; Bos E; Verheijden GF; Berheijden G; Miltenburg AM; Rijnders AW; Veys EM; De Keyser F
Arthritis Rheum; 2000 Jun; 43(6):1233-43. PubMed ID: 10857782
[TBL] [Abstract][Full Text] [Related]
6. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.
Volck B; Johansen JS; Stoltenberg M; Garbarsch C; Price PA; Ostergaard M; Ostergaard K; Løvgreen-Nielsen P; Sonne-Holm S; Lorenzen I
Osteoarthritis Cartilage; 2001 Apr; 9(3):203-14. PubMed ID: 11300743
[TBL] [Abstract][Full Text] [Related]
7. Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.
van Lierop MJ; den Hoed L; Houbiers J; Vencovsky J; Ruzickova S; Krystufkova O; van Schaardenburg M; van den Hoogen F; Vandooren B; Baeten D; De Keyser F; Sønderstrup G; Bos E; Boots AM
Arthritis Rheum; 2007 Jul; 56(7):2150-9. PubMed ID: 17599744
[TBL] [Abstract][Full Text] [Related]
8. Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease.
Punzi L; Podswiadek M; D'Incà R; Zaninotto M; Bernardi D; Plebani M; Sturniolo GC
Ann Rheum Dis; 2003 Dec; 62(12):1224-6. PubMed ID: 14644865
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
10. Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis.
Sekine T; Masuko-Hongo K; Matsui T; Asahara H; Takigawa M; Nishioka K; Kato T
Ann Rheum Dis; 2001 Jan; 60(1):49-54. PubMed ID: 11114282
[TBL] [Abstract][Full Text] [Related]
11. Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker.
Baeten D; Steenbakkers PG; Rijnders AM; Boots AM; Veys EM; De Keyser F
Arthritis Rheum; 2004 Feb; 50(2):444-51. PubMed ID: 14872486
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
13. Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment.
Happonen KE; Saxne T; Geborek P; Andersson M; Bengtsson AA; Hesselstrand R; Heinegård D; Blom AM
Arthritis Res Ther; 2012 Jan; 14(1):R15. PubMed ID: 22264230
[TBL] [Abstract][Full Text] [Related]
14. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages.
Kirkpatrick RB; Emery JG; Connor JR; Dodds R; Lysko PG; Rosenberg M
Exp Cell Res; 1997 Nov; 237(1):46-54. PubMed ID: 9417865
[TBL] [Abstract][Full Text] [Related]
15. ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus.
Yolbas S; Kara M; Kalayci M; Yildirim A; Gundogdu B; Aydin S; Koca SS
Adv Clin Exp Med; 2018 Dec; 27(12):1637-1641. PubMed ID: 30141839
[TBL] [Abstract][Full Text] [Related]
16. Localization of MHC class II/human cartilage glycoprotein-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies.
Steenbakkers PG; Baeten D; Rovers E; Veys EM; Rijnders AW; Meijerink J; De Keyser F; Boots AM
J Immunol; 2003 Jun; 170(11):5719-27. PubMed ID: 12759455
[TBL] [Abstract][Full Text] [Related]
17. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis.
Verheijden GF; Rijnders AW; Bos E; Coenen-de Roo CJ; van Staveren CJ; Miltenburg AM; Meijerink JH; Elewaut D; de Keyser F; Veys E; Boots AM
Arthritis Rheum; 1997 Jun; 40(6):1115-25. PubMed ID: 9182922
[TBL] [Abstract][Full Text] [Related]
18. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization.
Connor JR; Dodds RA; Emery JG; Kirkpatrick RB; Rosenberg M; Gowen M
Osteoarthritis Cartilage; 2000 Mar; 8(2):87-95. PubMed ID: 10772238
[TBL] [Abstract][Full Text] [Related]
19. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis.
Shen C; Sun XG; Liu N; Mu Y; Hong CC; Wei W; Zheng F
Mol Med Rep; 2015 Feb; 11(2):1528-34. PubMed ID: 25352049
[TBL] [Abstract][Full Text] [Related]
20. Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity.
Peltomaa R; Paimela L; Harvey S; Helve T; Leirisalo-Repo M
Rheumatol Int; 2001 Jul; 20(5):192-6. PubMed ID: 11518039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
